The Appointment of our Scientific Officer
Cyclife Aquila Nuclear have been involved in the nuclear industry for the past 40 years with experience from every licensed nuclear site in the UK. Within the nuclear medicine sector, we have had an enviable track record in the design, manufacture, and installation of radiopharmaceutical systems throughout Europe. With our growing expertise and reputation, we are committed to being thought leaders within the nuclear medicine sector.
CAN’s Involvement in the Nuclear Medicine Sector
So, what is nuclear medicine and how are CAN involved? Nuclear medicine is a medical speciality that uses radioactive materials, known as radioisotopes or radiopharmaceuticals, to either treat or diagnose medical conditions by inserting the nuclear substance into the body. Once the substance is either ingested, inhaled, or injected into the body the doctor will begin taking photographs using Positron Emission Tomography (PET) or Single-Photon Emission Computed Tomography (SPECT). This will then flag an abnormality and result in a diagnosis. The same substance can also be used to treat medical conditions such as cancer. This revolutionary technology makes the nuclear medicine sector an exciting one to be a part of.
Dave Barker, Director of Strategy, recognises the importance of being a part of this sector and goes on to tell us about CAN’s involvement: “CAN serves all nuclear sectors including the ever-advancing field of nuclear medicines. At CAN we work with hospitals and research organisations throughout Europe. CAN specialises in the development of processes integrated within hot cells for new radioisotopes for diagnostics and therapy. The latest technologies include targeted alpha therapies which have the possibility of revolutionising treatment for cancer patients.”
You can read more about our work here: CAN & Nuclear Medicine
The Appointment of our Scientific Officer
With the global direction in targeted alpha therapies, we decided to appoint a Scientific Officer, a brand-new role to CAN. Amin Choudhury joined CAN in May this year, he supports our engineering capability in the radiochemical and clinical aspects of radiopharmaceutical production. Amin also supports the commercial and delivery teams, providing leadership in nuclear medicine technology as well as shaping our progress into the growing nuclear medicine market globally.
Amin also develops relationships with academia, clients, the supply chain, and trade bodies to help Nuclear Medicine capabilities and services at CAN. Here is what he has to say about joining CAN with details on his past experiences and what he has brought to the team so far:
“I have over 6 years of GMP experience, including; 4 years of Nuclear Medicine experience, over a year in ATMP (Advanced Therapy Medicinal Products) and most recently, Irradiation of Medical Devices. My Nuclear Medicine experience includes cyclotron produced F18 products which were terminally sterilised in autoclaves -to- Ga68 products from generators which were manufactured under aseptic conditions. The most valuable experience I have is being part of a new-build project to open a radiopharmacy in London where I enhanced my knowledgeable in Validation systems and Quality Systems. A skill I am proud to carry forward into my role as Scientific Officer is Innovation, where I have practical experience in modifying HotCells to meet the needs of operations and regulations, and practical experience working with various chemistry modules and dispensing modules within these isolators. I see my role as a bridge between CAN and the client, where the knowledge in Nuclear Medicine provides trust and support for the client when searching for solutions with CAN, additionally, with the renewed in-house knowledge, CAN offers pragmatic and innovative solutions to the Nuclear Medicine industry in an effective and assured manner.”
Over the past few months, Amin has demonstrated a real depth of experience which is helping us achieve a stronger understanding of Nuclear Medicine and how we can enhance our solutions and capabilities to serve our clients, showcasing our commitment to being thought leaders within the sector.
Strengthening our Knowledge
Another way we have been strengthening our knowledge is through industry events and conferences. In May, Dave Barker, Director of Strategy and Paul Adlem, Customer Manager flew out to Belfast to attend the British Nuclear Medicine Society’s (BNMS) Annual Spring Meeting. The conference explored pioneering innovations in Nuclear Medicine, Therapeutics and Diagnostics and continually serves as a central hub for professionals and organisations dedicated to nuclear medicine. Amin and Paul will also be attending the BNMS Autumn Meeting later in October.
CAN’S presence at these events highlight our crucial commitment to innovation, research, and development in the realm of life-saving nuclear therapeutics and diagnostics. A core aspect of our mission is our ability to ensure timely availability and safe handling of nuclear materials crucial for nuclear medical advancements. Handling radioactive materials requires stringent safety protocols and state-of-the-art facilities to prevent contamination and ensure the well-being of researchers and patients. Our facilities are equipped with advanced technology to manage these risks effectively, supporting the continuous innovation of diagnostic and therapeutic methods.
We are thrilled about the future of Nuclear Medicine at CAN, our growing expertise in the nuclear medicine sector positions us as a key player. Now with Amin on the team, we can further strengthen our knowledge and capabilities, solidifying our role as thought leaders in the industry.
Paul and Dave at the BNMS Annual Spring Meeting 2024
Cyclife Aquila Nuclear visits Barton Peveril Sixth Form College
Barton Peveril Sixth Form College hosted an exhilarating Physics Tournament on Tuesday 9th July. The event welcomed over 40 Year 10 students from the following schools: Thornden, Crestwood, Mountbatten, and Wildern. The tournament aimed to inspire and challenge young minds while showcasing the exciting possibilities within the realm of physics.
Teams of students competed against each other in a race to unlock a series of boxes. To achieve this, they had to decipher a range of intricate physics puzzles, testing their knowledge, ingenuity, and teamwork. Throughout the challenge, the participants demonstrated exceptional problem-solving abilities and unwavering determination.
“I was really impressed with the methodical approach that the Year 10 teams took to what was a very challenging set of puzzles. I was particularly encouraged by how the students tackled problems together as a team, rather than panicking and losing concentration. Engineering is all about working in teams with people of different skillsets, backgrounds and methods; so a challenge like this was the perfect opportunity to develop these skills. Based on my experience on Tuesday, the future of STEM in the UK seems very bright!”
Matt Fowler, Senior Mechanical Design Engineer for Cyclife Aquila Nuclear
After an intense competition, an all-girls team from Thornden emerged victorious. The team showed remarkable efficiency, unlocking their box in an astounding time of 34 minutes.
– Press release written and published by Barton Peveril Sixth Form College (Physics Tournament Showcases Future Scientists | Barton Peveril Sixth Form College (barton-peveril.ac.uk))
CAN x Always Another Way
Cyclife Aquila Nuclear has been working alongside Always Another Way in recent years. Always Another Way is a charity set up to improve mental wellbeing in West Cumbria, particularly in Copeland and Allerdale.
Their aim is to provide comprehensive and tailored mental wellbeing support through a range of services including coping strategies, connect groups, alternative therapies, colour coded (LGBTQ+) groups, mental wellbeing courses and personal therapy. All of these services are free and funded by donations and support from the wider community.
As part of our social value commitments, CAN has been supporting Always Another Way with general assistance, marketing advice and donations. Our marketing department has been working closely with the charity to support them with their social media and website presence, enhancing their profile and ensuring their messages are communicated clearly and consistently. In this way, we are helping them to raise awareness of the services they offer. It is truly wonderful to see the amount of work they do to help others in need, we are very fortunate to get to work with them.
Lyn Cavaghan, Executive Officer shares her thoughts on the partnership, she says:
“We have had the pleasure of partnering with Cyclife Aquila Nuclear, who have significantly supported our organisation in various ways. They have provided invaluable assistance and guidance with bid preparation and grant writing, attended our AGM and Vision Day for our team, which helped define our new mission, continued social media support, and made a very generous donation. Their contributions have been instrumental in advancing our work and impact locally. We are deeply grateful for their support and commitment to our cause, which has enabled us to better serve our community and achieve our goals.”
We are excited to continue working with Always Another Way and look forward to seeing what the future holds for them as they continue to grow!
* Always Another Way with the Fri Connect Group visiting the bees!
Cyclife Aquila Nuclear at BNMS Belfast: Pioneering Innovation in Nuclear Medicine, Therapeutics and Diagnostics
Cyclife Aquila Nuclear’s participation at the BNMS (British Nuclear Medicine Society) conference in Belfast underscores a crucial commitment to innovation, research, and development in the realm of life-saving nuclear therapeutics and diagnostics. This presence highlights the company’s pivotal role in ensuring the timely availability and safe handling of nuclear materials crucial for nuclear medical advancements.
Bridging Innovation and Safety in Nuclear Medicine
The BNMS conference serves as a central hub for professionals and organisations dedicated to nuclear medicine. CAN’s engagement at this event is driven by a clear objective: to support and enhance the landscape of medical treatment procedures that rely on nuclear technology.
Advancing Diagnostic and Therapeutic Technologies
Nuclear medicine is a critical field that encompasses a range of diagnostic and therapeutic techniques, including PET (Positron Emission Tomography) scans, SPECT (Single Photon Emission Computed Tomography), and various radiopharmaceuticals used in treating conditions such as cancer. CAN’s expertise in managing and innovating within the nuclear sector positions them as a key player in the development of these life-saving technologies.
Ensuring Safe and Secure Research Environments
A core aspect of CAN’s mission is to provide safe and secure facilities for the research and development of nuclear diagnostics and medicines. Handling radioactive materials requires stringent safety protocols and state-of-the-art facilities to prevent contamination and ensure the well-being of researchers and patients. CAN’s facilities are equipped with advanced technology to manage these risks effectively, supporting the continuous innovation of diagnostic and therapeutic methods.
Supporting the UK’s Nuclear Medicine Infrastructure
CAN’s commitment extends beyond individual research projects to support the broader infrastructure necessary for the UK’s nuclear medicine sector. Their involvement at BNMS Belfast highlights several key initiatives:
- Collaboration with Research Institutions: By partnering with leading research institutions, CAN helps drive forward groundbreaking studies and the development of new therapeutic and diagnostic radioisotopes particularly in the growing field of targeted alpha therapies.
- Regulatory Compliance and Safety Standards: Ensuring that all operations comply with the highest safety standards and regulatory requirements is a cornerstone of CAN’s approach, fostering trust and reliability within the industry.
- Innovative Handling Apparatus: Developing and providing advanced handling apparatus ensures that radioactive materials are managed with utmost precision, minimising risk, and enhancing the efficacy of research outcomes.
A Commitment to a Secure and Innovative Future
The BNMS conference in Belfast is more than just an event; it’s a testament to the ongoing efforts and dedication of professionals like those at CAN who are committed to pioneering advancements in nuclear medicine. Their work ensures that the UK remains at the forefront of medical research and development, continually pushing the boundaries of what is possible in diagnostics and treatment.
By attending BNMS, CAN showcased their capabilities and reaffirmed their dedication to supporting a secure, innovative, and efficient supply chain for nuclear materials critical to the health and well-being of countless individuals. Their role in this ecosystem is indispensable, ensuring that life-saving diagnostics and medicines are developed in safe, controlled, and cutting-edge environments.
CAN’s presence at BNMS Belfast is a powerful statement of our commitment to the future of nuclear medicine. Through their expertise in safe facility management, secure transportation, and unwavering support for innovation, they are helping to shape a healthier, more advanced future for the UK and beyond.
Mental Health Awareness Week 2024
Last week Cyclife Aquila Nuclear participated in Mental Health Awareness Week. It was an excellent opportunity to learn about the different types of mental health issues and break the stigma surrounding the topic. Every year, 1 in 4 people experience a mental health problem in England so it is important that we gain as much knowledge as possible on this topic.
CAN is dedicated to ensuring that all employees know what help, support, and resources they can get whilst at the workplace. We have two first aid trainers who have been trained and equipped with the skills to assist anyone facing a mental health challenge. As well as this, we have an internal toolkit for line managers and training for all employees on the different types of mental health issues and what to do if they notice that a colleague is struggling. By doing this, we ensure that all of our employees know how to access our resources.
As this year’s Mental Health Awareness Week theme is movement, we encourage you to incorporate this into your daily routine, even if it is taking a walk during your lunch break, going for a run, attending a sports class, or anything else. Simply moving your body will help to get those endorphins flowing. Endorphins can help improve your mood, reduce anxiety, and help you manage stress more effectively. Some other activities you could do to help improve your mental health include talking to your family and friends about how you’re feeling, eating healthy foods, practicing self-care and mindfulness, and ensuring you sleep for at least 8 hours.
To raise awareness and show support, the CAN team participated in Mental Health Foundation’s ‘Wear It Green Day’ in support of mental health – it was a great opportunity to have open conversations about how CAN can support our employees, beyond access to our mental health first aiders. What a turn out we had! It was great to see so many of our colleagues dress for the occasion including employees from the finance, admin, HR, commercial, engineering and project management teams.
Overall, this week has been extremely insightful, and we will continue to show our support for mental health throughout the year and ensure we are continually raising awareness and supporting those who need it.